Loreto
Carmona Ortells
Hospital General Universitario de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (6)
2022
-
Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab
Reumatologia Clinica, Vol. 18, Núm. 1, pp. 25-29
-
Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab
Reumatologia clinica, Vol. 18, Núm. 1, pp. 25-29
2012
-
Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: Data from the Spanish registry BIOBADASER 2.0
Annals of the Rheumatic Diseases, Vol. 71, Núm. 3, pp. 382-385
2010
-
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
Annals of the Rheumatic Diseases, Vol. 69, Núm. 10, pp. 1751-1755
2008
-
Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas
Reumatologia Clinica, Vol. 4, Núm. 3, pp. 90-95
2006
-
Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period
Arthritis Research and Therapy, Vol. 8, Núm. 1